DNA X, Inc. - Common Stock, par value $0.001 per share (SONM)

CUSIP: 83548F309

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
1,121,613
Total 13F shares
238,785
Share change
+113,266
Total reported value
$291,698
Price per share
$1.22
Number of holders
19
Value change
+$63,379
Number of buys
16
Number of sells
3

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 83548F309?
CUSIP 83548F309 identifies SONM - DNA X, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SONM - DNA X, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AJP Holding Company, LLC
3/4/5 13D/G
10%+ Owner · Jeffrey Wang
19%
from 13D/G
19,463,452
$8,155,186 08 Aug 2022
Orbic North America LLC
3/4/5 13D/G
10%+ Owner
33%
from 13D/G
1,947,345
$6,387,292 11 Mar 2025
Jeffrey Wang
3/4/5
Director
175%
1,967,647
$4,118,212 -$6,493 23 Apr 2025
BRC Group Holdings, Inc.
3/4/5
10%+ Owner
class O/S missing
7,700,228
$3,226,397 23 Aug 2021
Hao Peter Liu
3/4/5
Chief Executive Officer, Director
class O/S missing
269,388
$883,593 06 Feb 2025
MORGAN STANLEY
3/4/5
10%+ Owner
class O/S missing
846,629
$354,738 12 Oct 2021
Robert L. Tirva
3/4/5
Former President, CFO & COO
class O/S missing
314,619
$131,825 13 Jul 2022
VANGUARD GROUP INC
13F
Company
4.5%
50,534
$108,143 31 Mar 2025
13F
Charles Becher
3/4/5
Chief Commercial Officer and General Manager of North America
5.6%
62,668
$90,868 -$45,423 23 Apr 2025
Alan B. Howe
3/4/5
Director
class O/S missing
176,403
$73,913 24 Mar 2023
Jack Steenstra
3/4/5
Director
4.4%
49,139
$71,251 -$33,902 23 Apr 2025
James S. Cassano
3/4/5
Director
4.4%
49,126
$71,232 -$33,902 23 Apr 2025
Jose Carlos Principe
3/4/5
Director
class O/S missing
149,426
$62,609 18 Nov 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.1%
23,135
$49,518 31 Mar 2025
13F
UBS Group AG
13F
Company
1.6%
17,748
$37,981 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.4%
15,706
$33,611 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.4%
15,481
$33,129 31 Mar 2025
13F
Kenneth Dale Naumann
3/4/5
Director
class O/S missing
66,265
$27,765 17 Jun 2021
John Kneuer
3/4/5
Director
class O/S missing
40,220
$16,852 12 Nov 2021
Susan Swenson
3/4/5
Director
class O/S missing
39,806
$16,679 12 Nov 2021
Tower Research Capital LLC (TRC)
13F
Company
0.19%
2,155
$4,612 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.06%
655
$1,402 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
71
$153 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
21
$45 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
6
$13 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
6
$12 31 Mar 2025
13F
DANSKE BANK A/S
13F
Company
0%
1
$2 31 Mar 2025
13F

Institutional Holders of DNA X, Inc. - Common Stock, par value $0.001 per share (SONM) as of Q2 2025

As of 30 Jun 2025, DNA X, Inc. - Common Stock, par value $0.001 per share (SONM) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 238,785 shares. The largest 10 holders included UBS Group AG, TWO SIGMA SECURITIES, LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, StoneX Group Inc., RENAISSANCE TECHNOLOGIES LLC, CITIGROUP INC, BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC (TRC). This page lists 20 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
12
Q2 2025 holders
19
Holder diff
7
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.